Tech Company Financing Transactions
Xagenic Funding Round
Xagenic, operating out of Toronto ON, secured $5.5 million in investment from BDC Venture Capital.
Transaction Overview
Company Name
Announced On
7/14/2014
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Series B
Investors
BDC Venture Capital (Dion Madsen)
Proceeds Purpose
Securing this additional financing from high-quality new and existing investors demonstrates confidence in the Xagenic X1 platform. We look forward to continuing our development program in anticipation of our analytical and clinical study start later this year.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
55 York St. 1000
Toronto ON, M5J 1R7
Canada
Toronto ON, M5J 1R7
Canada
Phone
Website
Email Address
Overview
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shana Kelley
Chief Financial Officer
Edward Jonasson
Chief Operating Officer
Randall Wilhoite
VP - R & D
Graham Jack
Browse more venture capital transactions:
Prev: 7/14/2014: Landscape Mobile venture capital transaction
Next: 7/14/2014: Punchbowl Software venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs